+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Mucopolysaccharidosis (MPS) Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 - Product Thumbnail Image

Mucopolysaccharidosis (MPS) Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Report
  • September 2020
From
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 - Product Thumbnail Image

Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021

  • Report
  • September 2021
  • 1900 pages
From
Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026

  • Report
  • January 2020
  • 1500 Pages
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
From
Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024 - Product Thumbnail Image

Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024

  • Report
  • October 2019
From
COVID-19 Therapy and Vaccine Drug Pipeline Market Report- 2021 Update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline Market Report- 2021 Update

  • Report
  • January 2021
  • 500 Pages
From
COVID-19 Therapy and Vaccine Drug Pipeline Market Report - September 2020 Update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline Market Report - September 2020 Update

  • Report
  • September 2020
  • 512 Pages
From
COVID Treatment and Vaccine Drug Pipeline Report- July 2020 Update - Product Thumbnail Image

COVID Treatment and Vaccine Drug Pipeline Report- July 2020 Update

  • Report
  • July 2020
  • 170 Pages
From
Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines - Product Thumbnail Image

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines

  • Report
  • May 2021
  • 62 pages
From
Oligonucleotide Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030 - Product Thumbnail Image

Oligonucleotide Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030

  • Report
  • June 2021
From
Oligonucleotide Therapy Global Market Report 2020-30: COVID-19 Growth and Change - Product Thumbnail Image

Oligonucleotide Therapy Global Market Report 2020-30: COVID-19 Growth and Change

  • Report
  • November 2020
From
Angelman Syndrome Market Insights, Epidemiology, and Market Forecast - 2030 - Product Thumbnail Image

Angelman Syndrome Market Insights, Epidemiology, and Market Forecast - 2030

  • Report
  • July 2020
  • 132 pages
From
Niemann-Pick Type C Disease - Pipeline Insight, 2021 - Product Thumbnail Image

Niemann-Pick Type C Disease - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 pages
From
Pompe Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Pompe Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 104 pages
From
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 164 pages
From
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2019 - Product Thumbnail Image

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2019

  • Report
  • February 2020
  • 108 pages
From
Survival Motor Neuron Protein - Pipeline Review, H1 2020 - Product Thumbnail Image

Survival Motor Neuron Protein - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 92 pages
From
Multiple Sclerosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1114 pages
From
2020 Spinal Muscular Atrophy (SMA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Spinal Muscular Atrophy (SMA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 116 pages
From
2020 Rett Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Rett Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 106 pages
From
Loading Indicator
adroll